Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P.A. Laires

Pcv34 - A Review Assessing the Incidence and Prevalence of Chronic Heart Failure With Preserved Ejection Fraction

Value in Health

English

Pnd136 - Functional, Emotional and Social Impact of Migraine in Portugal

English

Pcv150 - Health Care Resource Use and Quality of Life in Patients Prescribed With Sacubitril/Valsartan in Portugal: A Cross-Sectional Observational Study (Prime Study)

English

Pcv147 - A Targeted Literature Review of Health State Utilities in Heart Failure With Preserved Ejection Fraction (Hfpef)

English

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

English

Pss29 - Secukinumab Versus Etanercept for the Treatment of Psoriasis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective

English

Pms89 - Development of an Outcomes Measurement Tool to Evaluate the Quality of Biologic Switch in Psoriatic Arthritis

English

Pss35 - Secukinumab Versus Ustekinumab for the Treatment of Psoriasis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective

English

Pmu6 - The Relationship Between Integration Disability Policies and Intention of Early Retirement Within a Context of Multimorbidity: Results From the Survey of Health, Ageing and Retirement in Europe (Share)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P.A. Laires

Pcv34 - A Review Assessing the Incidence and Prevalence of Chronic Heart Failure With Preserved Ejection Fraction

Pnd136 - Functional, Emotional and Social Impact of Migraine in Portugal

Pcv150 - Health Care Resource Use and Quality of Life in Patients Prescribed With Sacubitril/Valsartan in Portugal: A Cross-Sectional Observational Study (Prime Study)

Pcv147 - A Targeted Literature Review of Health State Utilities in Heart Failure With Preserved Ejection Fraction (Hfpef)

Pcv6 - Sacubitril/Valsartan in Heart Failure: Projected Health Outcomes in Portugal

Pss29 - Secukinumab Versus Etanercept for the Treatment of Psoriasis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective

Pms89 - Development of an Outcomes Measurement Tool to Evaluate the Quality of Biologic Switch in Psoriatic Arthritis

Pss35 - Secukinumab Versus Ustekinumab for the Treatment of Psoriasis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective

Pmu6 - The Relationship Between Integration Disability Policies and Intention of Early Retirement Within a Context of Multimorbidity: Results From the Survey of Health, Ageing and Retirement in Europe (Share)